{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:24:29Z","timestamp":1787984669273,"version":"build-2784847793"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"DOI":"10.1007\/s10689-026-00529-4","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T06:57:43Z","timestamp":1770101863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Attenuated Li\u2013Fraumeni syndrome with TP53 p.R181H in a Japanese patient with metastatic rectal adenocarcinoma: a case report"],"prefix":"10.1007","volume":"25","author":[{"given":"Yuki","family":"Kasahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Niihori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maako","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinnosuke","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Shirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Saijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroo","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Komine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Ouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakura","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryunosuke","family":"Numakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiori","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Shirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikashi","family":"Ishioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisato","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"issue":"21","key":"529_CR1","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","volume":"33","author":"G Bougeard","year":"2015","unstructured":"Bougeard G, Renaux-Petel M, Flaman JM et al (2015) Revisiting Li-Fraumeni syndrome from TP53 mutation carriers. J Clin Oncol 33(21):2345\u20132352. https:\/\/doi.org\/10.1200\/JCO.2014.59.5728","journal-title":"J Clin Oncol"},{"issue":"4","key":"529_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/bjh.14461","volume":"176","author":"JM Valdez","year":"2017","unstructured":"Valdez JM, Nichols KE, Kesserwan C (2017) Li-Fraumeni syndrome: a paradigm for the Understanding of hereditary cancer predisposition. Br J Haematol 176(4):539\u2013552. https:\/\/doi.org\/10.1111\/bjh.14461","journal-title":"Br J Haematol"},{"issue":"5","key":"529_CR3","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1080\/08998280.2022.2071100","volume":"35","author":"J Ogden","year":"2022","unstructured":"Ogden J, Pippen J (2022) Presentation, diagnosis, and management of the Li-Fraumeni syndrome. Proc (Bayl Univ Med Cent) 35(5):678\u2013679. https:\/\/doi.org\/10.1080\/08998280.2022.2071100","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"2","key":"529_CR4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1055\/s-0036-1579759","volume":"5","author":"H Correa","year":"2016","unstructured":"Correa H (2016) Li-Fraumeni syndrome. J Pediatr Genet 5(2):84\u201388. https:\/\/doi.org\/10.1055\/s-0036-1579759","journal-title":"J Pediatr Genet"},{"issue":"12","key":"529_CR5","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/S1470-2045(21)00580-5","volume":"22","author":"KC de Andrade","year":"2021","unstructured":"de Andrade KC, Khincha PP, Hatton JN et al (2021) Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study. Lancet Oncol 22(12):1787\u20131798. https:\/\/doi.org\/10.1016\/S1470-2045(21)00580-5","journal-title":"Lancet Oncol"},{"issue":"1","key":"529_CR6","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/cdd.2017.180","volume":"25","author":"EH Baugh","year":"2018","unstructured":"Baugh EH, Ke H, Levine AJ, Bonneau RA, Chan CS (2018) Why are there hotspot mutations in the TP53 gene in human cancers? Cell Death Differ 25(1):154\u2013160. https:\/\/doi.org\/10.1038\/cdd.2017.180","journal-title":"Cell Death Differ"},{"issue":"10","key":"529_CR7","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/jnci\/djad106","volume":"115","author":"NW Fischer","year":"2023","unstructured":"Fischer NW, Ma YV, Gariepy J (2023) Emerging insights into ethnic-specific TP53 germline variants. J Natl Cancer Inst 115(10):1145\u20131156. https:\/\/doi.org\/10.1093\/jnci\/djad106","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"529_CR8","doi-asserted-by":"publisher","first-page":"20368","DOI":"10.1038\/s41598-020-74892-2","volume":"10","author":"V Carbonnier","year":"2020","unstructured":"Carbonnier V, Leroy B, Rosenberg S, Soussi T (2020) Comprehensive assessment of TP53 loss of function using multiple combinatorial mutagenesis libraries. Sci Rep 10(1):20368. https:\/\/doi.org\/10.1038\/s41598-020-74892-2","journal-title":"Sci Rep"},{"issue":"23","key":"529_CR9","doi-asserted-by":"publisher","first-page":"7243","DOI":"10.1182\/bloodadvances.2023011384","volume":"7","author":"DJ Landsburg","year":"2023","unstructured":"Landsburg DJ, Morrissette JJ, Nasta SD et al (2023) TP53 mutations predict for poor outcomes in patients with newly diagnosed aggressive B-cell lymphomas in the current era. Blood Adv 7(23):7243\u20137253. https:\/\/doi.org\/10.1182\/bloodadvances.2023011384","journal-title":"Blood Adv"},{"issue":"14","key":"529_CR10","doi-asserted-by":"publisher","first-page":"8424","DOI":"10.1073\/pnas.1431692100","volume":"100","author":"S Kato","year":"2003","unstructured":"Kato S, Han SY, Liu W et al (2003) Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc Natl Acad Sci U S A 100(14):8424\u20138429. https:\/\/doi.org\/10.1073\/pnas.1431692100","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"529_CR11","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1001\/jamaoncol.2021.4398","volume":"7","author":"CP Kratz","year":"2021","unstructured":"Kratz CP, Freycon C, Maxwell KN et al (2021) Analysis of the Li-Fraumeni spectrum based on an international germline TP53 variant data set: an international agency for research on cancer TP53 database analysis. JAMA Oncol 7(12):1800\u20131805. https:\/\/doi.org\/10.1001\/jamaoncol.2021.4398","journal-title":"JAMA Oncol"},{"issue":"1","key":"529_CR12","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1074\/jbc.M310815200","volume":"279","author":"K Shiraishi","year":"2004","unstructured":"Shiraishi K, Kato S, Han SY et al (2004) Isolation of temperature-sensitive p53 mutations from a comprehensive missense mutation library. J Biol Chem 279(1):348\u2013355. https:\/\/doi.org\/10.1074\/jbc.M310815200","journal-title":"J Biol Chem"},{"issue":"3","key":"529_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/humu.24152","volume":"42","author":"C Fortuno","year":"2021","unstructured":"Fortuno C, Lee K, Olivier M et al (2021) Specifications of the ACMG\/AMP variant interpretation guidelines for germline TP53 variants. Hum Mutat 42(3):223\u2013236. https:\/\/doi.org\/10.1002\/humu.24152","journal-title":"Hum Mutat"},{"issue":"12","key":"529_CR14","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/humu.23320","volume":"38","author":"KC de Andrade","year":"2017","unstructured":"de Andrade KC, Mirabello L, Stewart DR et al (2017) Higher-than-expected population prevalence of potentially pathogenic germline TP53 variants in individuals unselected for cancer history. Hum Mutat 38(12):1723\u20131730. https:\/\/doi.org\/10.1002\/humu.23320","journal-title":"Hum Mutat"},{"issue":"1","key":"529_CR15","doi-asserted-by":"publisher","first-page":"100242","DOI":"10.1016\/j.xhgg.2023.100242","volume":"5","author":"KC de Andrade","year":"2024","unstructured":"de Andrade KC, Strande NT, Kim J et al (2024) Genome-first approach of the prevalence and cancer phenotypes of pathogenic or likely pathogenic germline TP53 variants. HGG Adv 5(1):100242. https:\/\/doi.org\/10.1016\/j.xhgg.2023.100242","journal-title":"HGG Adv"},{"issue":"6","key":"529_CR16","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1136\/gutjnl-2020-321825","volume":"70","author":"M Terradas","year":"2021","unstructured":"Terradas M, Mur P, Belhadj S et al (2021) TP53, a gene for colorectal cancer predisposition in the absence of Li-Fraumeni-associated phenotypes. Gut 70(6):1139\u20131146. https:\/\/doi.org\/10.1136\/gutjnl-2020-321825","journal-title":"Gut"},{"issue":"4","key":"529_CR17","doi-asserted-by":"publisher","first-page":"100484","DOI":"10.1016\/j.xhgg.2025.100484","volume":"6","author":"C Fortuno","year":"2025","unstructured":"Fortuno C, Richardson ME, Pesaran T, McGoldrick K, James PA, Spurdle AB (2025) Characteristics predicting reduced penetrance variants in the high-risk cancer predisposition gene TP53. HGG Adv 6(4):100484. https:\/\/doi.org\/10.1016\/j.xhgg.2025.100484","journal-title":"HGG Adv"},{"issue":"5","key":"529_CR18","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/s41418-022-00976-3","volume":"29","author":"KC de Andrade","year":"2022","unstructured":"de Andrade KC, Lee EE, Tookmanian EM et al (2022) The TP53 database: transition from the international agency for research on cancer to the US National cancer Institute. Cell Death Differ 29(5):1071\u20131073. https:\/\/doi.org\/10.1038\/s41418-022-00976-3","journal-title":"Cell Death Differ"},{"issue":"30","key":"529_CR19","doi-asserted-by":"publisher","first-page":"7518","DOI":"10.1200\/JCO.2005.00.471","volume":"23","author":"A Russo","year":"2005","unstructured":"Russo A, Bazan V, Iacopetta B et al (2005) The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment. J Clin Oncol 23(30):7518\u20137528. https:\/\/doi.org\/10.1200\/JCO.2005.00.471","journal-title":"J Clin Oncol"},{"issue":"2","key":"529_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.20517\/cdr.2022.136","volume":"6","author":"WH Gmeiner","year":"2023","unstructured":"Gmeiner WH, Okechukwu CC (2023) Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects. Cancer Drug Resist 6(2):257\u2013272. https:\/\/doi.org\/10.20517\/cdr.2022.136","journal-title":"Cancer Drug Resist"},{"issue":"4","key":"529_CR21","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s10689-024-00419-7","volume":"23","author":"C Freycon","year":"2024","unstructured":"Freycon C, Palma L, Budd C et al (2024) Germline p.R181H variant in TP53 in a family exemplifying the genotype-phenotype correlations in Li-Fraumeni syndrome. Fam Cancer 23(4):665\u2013669. https:\/\/doi.org\/10.1007\/s10689-024-00419-7","journal-title":"Fam Cancer"},{"issue":"5","key":"529_CR22","doi-asserted-by":"publisher","first-page":"e2213070","DOI":"10.1001\/jamanetworkopen.2022.13070","volume":"5","author":"TA Yap","year":"2022","unstructured":"Yap TA, Ashok A, Stoll J et al (2022) Prevalence of germline findings among tumors from cancer types lacking hereditary testing guidelines. JAMA Netw Open 5(5):e2213070. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.13070","journal-title":"JAMA Netw Open"},{"issue":"4","key":"529_CR23","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41431-024-01753-1","volume":"33","author":"M Omran","year":"2025","unstructured":"Omran M, Liu Y, Sun Zhang A et al (2025) Characterisation of heritable TP53-related cancer syndrome in Sweden-a nationwide study of genotype-phenotype correlations in 90 families. Eur J Hum Genet 33(4):513\u2013522. https:\/\/doi.org\/10.1038\/s41431-024-01753-1","journal-title":"Eur J Hum Genet"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-026-00529-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-026-00529-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-026-00529-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T06:57:44Z","timestamp":1770101864000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-026-00529-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["529"],"URL":"https:\/\/doi.org\/10.1007\/s10689-026-00529-4","relation":{},"ISSN":["1573-7292"],"issn-type":[{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"17 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent for genetic testing and publication was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"18"}}